☆ 4.8 Letter

Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections

NEW ENGLAND JOURNAL OF MEDICINE (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。
Article Immunology

Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting

Laith J. Abu-Raddad et al.

Summary: A study in Qatar found a low rate of reinfection with SARS-CoV-2, with most cases being asymptomatic and suggesting protective immunity lasting for at least a few months post primary infection.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹
Article Multidisciplinary Sciences

Immunological characteristics govern the transition of COVID-19 to endemicity

Jennie S. Lavine et al.

Summary: The study suggests that infection-blocking immunity to SARS-CoV-2 wanes rapidly while disease-reducing immunity is long-lived. The model predicts that once reaching endemic phase, SARS-CoV-2 may become no more virulent than the common cold. However, a different outcome is predicted for an emergent coronavirus causing severe disease in children.

SCIENCE (2021)

添加到收藏夹
Letter Medicine, General & Internal

Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants

Laith J. Abu-Raddad et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹
Article Medicine, General & Internal

SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy

Laith J. Abu-Raddad et al.

Summary: The study shows that reinfection is rare in Qatar's young and international population, with natural infection providing strong protection against reinfection with an estimated efficacy of around 95% for at least seven months. Reinfections are often less severe than primary infections.

ECLINICALMEDICINE (2021)

添加到收藏夹
研讨会 海报 问题 讨论圈 基金 期刊 论文 科研社交 资讯集成 审稿人 关于我们 常见问题 移动App 隐私条款 使用条款
© Peeref 2019-2024. All rights reserved.